Fondazione Telethon

Following eight-year ‘pilot experiment’ in Italy, the firm’s Biovelocita now builds companies across Europe

European firm to invest fresh cash across all company stages amid changes in LP base, portfolio composition

BioCentury’s weekly Venture Report also includes Arch’s latest fund, Flagship-backed Mirai, series Bs for Vicebio and 858, and more

At least 12 Italian start-ups have attracted seed or series A funding since 2020, with Sofinnova and Claris the most active VCs

European firm’s Seghezzi: Momentum building for scientific deal flow as region draws funding, teams, infrastructure

Plus Innovent, Lilly expand oncology partnership and updates from InnoRNA, ImmunoGen and more

Sofinnova’s Papiernik: Heightened interest from U.S. VCs to join European syndicates at early stage

Emerging Company Profile: Milan-based Genespire is developing high-efficiency

The Leber congenital amaurosis pipeline includes at least 10 products in development targeting the most common genetic causes of the disease, including seven gene therapies, a gene editing candidate,

CHMP recommends conditional approval of Pfizer-BioNTech COVID-19 vaccineEMA’s CHMP recommended granting a conditional MAA for Comirnaty (BNT162b2) from Pfizer Inc. (NYSE:PFE) and BioNTech SE